• Following vessel injury, the extravasation of plasma borne molecules continues long after hemostasis occurs.• Limiting molecular extravasation is driven by platelet accumulation and retraction, but not fibrin deposition.Previous studies have shown that hemostatic thrombi formed in response to penetrating injuries have a core of densely packed, fibrin-associated platelets overlaid by a shell of less-activated, loosely packed platelets. Here we asked, first, how the diverse elements of this structure combine to stem the loss of plasma-borne molecules and, second, whether antiplatelet agents and anticoagulants that perturb thrombus structure affect the reestablishment of a tight vascular seal. The studies combined high-resolution intravital microscopy with a photo-activatable fluorescent albumin marker to simultaneously track thrombus formation and protein transport following injuries to mouse cremaster muscle venules. The results show that protein loss persists after red cell loss has ceased. Blocking platelet deposition with an a IIb b 3 antagonist delays vessel sealing and increases extravascular protein accumulation, as does either inhibiting adenosine 59-diphosphate (ADP) P2Y 12 receptors or reducing integrin-dependent signaling and retraction. In contrast, sealing was unaffected by introducing hirudin to block fibrin accumulation or a G i2 a gain-of-function mutation to expand the thrombus shell. Collectively, these observations describe a novel approach for studying vessel sealing after injury in real time in vivo and show that (1) the core/shell architecture previously observed in arterioles also occurs in venules, (2) plasma leakage persists well beyond red cell escape and mature thrombus formation, (3) the most critical events for limiting plasma extravasation are the stable accumulation of platelets, ADP-dependent signaling, and the emergence of a densely packed core, not the accumulation of fibrin, and (4) drugs that affect platelet accumulation and packing can delay vessel sealing, permitting protein escape to continue. (Blood. 2016;127(12):1598-1605
IntroductionRecent reports show that hemostatic thrombi formed in vivo in mice or ex vivo in studies using human blood develop a heterogeneous structure [1][2][3][4][5] in which a core of fully-activated platelets and fibrin is overlaid by a shell of less-activated platelets, forming a barrier that limits red cell loss. 6 A prominent characteristic of the core is that it consists of densely packed platelets, with increased packing density driven by contraction of crosslinked platelets through a IIb b 3 integrin-dependent outside-in signaling. [6][7][8][9] We have shown that the tighter packing within the thrombus core restricts molecular transport, helping to produce a region with increased local thrombin activity and greater platelet activation. Based on studies performed primarily in cremaster muscle arterioles, we proposed that this heterogeneous architecture is important for regulating the distribution of soluble agonists and, therefore, thrombus gr...